Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Technetium-99m-human serum albumin-indocyanine green is an investigational **hybrid radioactive-fluorescent sentinel lymph node mapping tracer** developed for intraoperative use in lung cancer surgery. It combines technetium-99m labeling for preoperative and intraoperative gamma-based localization with indocyanine green near-infrared fluorescence for real-time optical visualization. The human serum albumin-based carrier is intended to facilitate lymphatic drainage and retention in sentinel lymph nodes, enabling dual-modality identification of nodes that may contain metastatic disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on technetium-99m-human serum albumin-indocyanine green.